These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36935602)

  • 1. How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?
    Seo DM; Lee SM; Park JW; Kim MJ; Ha HI; Park SY; Lee K
    Ultrasonography; 2023 Apr; 42(2):227-237. PubMed ID: 36935602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease.
    Kuroda H; Abe T; Fujiwara Y; Nagasawa T; Takikawa Y
    J Med Ultrason (2001); 2021 Oct; 48(4):471-480. PubMed ID: 34415481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ultrasound-guided attenuation parameter is useful in quantification of hepatic steatosis in non-alcoholic fatty liver disease.
    Ogino Y; Wakui N; Nagai H; Igarashi Y
    JGH Open; 2021 Aug; 5(8):947-952. PubMed ID: 34386604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation and Performance of three Ultrasound Techniques to Stage Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
    Shen Q; Hao Y; Chen J; Liu Q; Jia H; Liu L
    Curr Med Imaging; 2024; 20():1-12. PubMed ID: 38389362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method.
    Bende F; Sporea I; Șirli R; Bâldea V; Lazăr A; Lupușoru R; Fofiu R; Popescu A
    Med Ultrason; 2021 Feb; 23(1):7-14. PubMed ID: 33220028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease.
    Fujiwara Y; Kuroda H; Abe T; Ishida K; Oguri T; Noguchi S; Sugai T; Kamiyama N; Takikawa Y
    Ultrasound Med Biol; 2018 Nov; 44(11):2223-2232. PubMed ID: 30077415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of a novel ultrasound-based quantitative method to assess liver steatosis in histologically identified nonalcoholic fatty liver disease.
    Kang KA; Lee SR; Jun DW; Do IG; Kim MS
    Med Ultrason; 2023 Mar; 25(1):7-13. PubMed ID: 36780603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of Ultrasound-Guided Attenuation Parameter for the Detection and Quantification of Hepatic Steatosis in Patients with Fatty Liver Diagnosed by Computed Tomography.
    Iwashita H; Shakado S; Yoshimaru N; Tanaka H; Koto F; Tanaka T; Takata K; Yokoyama K; Yamaguchi M; Irie M; Hirai F
    Ultrasound Med Biol; 2022 Jul; 48(7):1282-1289. PubMed ID: 35397929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort.
    Imajo K; Toyoda H; Yasuda S; Suzuki Y; Sugimoto K; Kuroda H; Akita T; Tanaka J; Yasui Y; Tamaki N; Kurosaki M; Izumi N; Nakajima A; Kumada T
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2533-2541.e7. PubMed ID: 34768008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and stability of ultrasound-guided attenuation parameter in evaluating hepatic steatosis.
    Zhang X; Luo L; Liu H; Liang S; Xu E
    J Ultrasound; 2024 Mar; 27(1):145-152. PubMed ID: 38281291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Diagnostic Value of Ultrasound-guided Attenuation Parameter (UGAP) in metabolic fatty liver disease.
    Wu H; Zeng Y; Chen F; Peng J; Chen L
    Curr Med Imaging; 2024 Feb; ():. PubMed ID: 38333977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound.
    Byenfeldt M; Kihlberg J; Nasr P; Grönlund C; Lindam A; Bartholomä WC; Lundberg P; Ekstedt M
    Eur Radiol; 2024 Mar; ():. PubMed ID: 38459346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis.
    Zhao Y; Jia M; Zhang C; Feng X; Chen J; Li Q; Zhang Y; Xu W; Dong Y; Jiang Y; Liu Y; Huang P
    Sci Rep; 2022 Feb; 12(1):2876. PubMed ID: 35190618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Stiffness Measurements by 2D Shear-Wave Elastography: Effect of Steatosis on Fibrosis Evaluation.
    Kumada T; Toyoda H; Yasuda S; Ogawa S; Gotoh T; Ito T; Tada T; Tanaka J
    AJR Am J Roentgenol; 2022 Oct; 219(4):604-612. PubMed ID: 35506556
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.
    Semmler G; Wöran K; Scheiner B; Unger LW; Paternostro R; Stift J; Schwabl P; Bucsics T; Bauer D; Simbrunner B; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
    United European Gastroenterol J; 2020 Apr; 8(3):321-331. PubMed ID: 32213023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic value of novel ultrasound attenuation analysis in detecting liver steatosis identified by the controlled attenuation parameter: a diagnostic accuracy study.
    Jiang M; Zhang X; Wu X; Xu Z; Pan J; He H; Luo Y; Chen J
    Ann Transl Med; 2023 Jan; 11(2):38. PubMed ID: 36819532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of hepatic steatosis with ultrasound: promising role of attenuation imaging coefficient in a biopsy-proven cohort.
    Dioguardi Burgio M; Ronot M; Reizine E; Rautou PE; Castera L; Paradis V; Garteiser P; Van Beers B; Vilgrain V
    Eur Radiol; 2020 Apr; 30(4):2293-2301. PubMed ID: 31822978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease.
    Jeon SK; Lee JM; Joo I; Yoon JH
    Ultrasonography; 2022 Apr; 41(2):355-364. PubMed ID: 34933319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.
    Chon YE; Jung KS; Kim SU; Park JY; Park YN; Kim DY; Ahn SH; Chon CY; Lee HW; Park Y; Han KH
    Liver Int; 2014 Jan; 34(1):102-9. PubMed ID: 24028214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.